GREENLION / PRECISION

Relief

CBD, CBG, CBC, CBN and CBL make up the Relief profile, accompanied by terpenes and THC fractions described in the composition.

mgPer bottle

mLPresentation

Reference profile CANNABINOIDS + TERPENES

CBD
CBG
CBC
CBN
CBL
Δ9-THC
THCA + THCV
Terpenes

Illustrative arcs use a logarithmic scale. See the percentages in the legend.

Illustrative images. Amounts and percentages are reference values and may vary between botanical batches. Consult your batch COA.

Request technical information Formulation and use guidance are defined by the prescriber. Consult the lot COA for analytical results.I have a prescription

LOT DOCUMENTATION

Consult the COA for Relief.

Choose the identification that matches the package. The certificate of analysis shows results for that specific lot.

Restricted accessSign in as a physician or patient to view certificates.

Medical area Patient sign in

Documentation becomes available after account authentication and profile validation.

PRECISION / RARE CANNABINOIDS

Meet the rare cannabinoids in Precision.

CBG, CBC, CBN and other minor forms add diversity beyond CBD. Explore the compounds in the three formulas and the research behind each. Rarity describes composition; suitability depends on clinical assessment.

CBD

Cannabidiol

The major cannabinoid in the line. Clinical literature is broader than for minor cannabinoids, but any effect depends on formulation, dose and clinical context.

View study · PubMed Explore further · CBD

CBG

Cannabigerol

A minor cannabinoid. Experimental studies investigate inflammatory and neurological pathways; clinical evidence remains limited.

View study · PubMed Explore further · CBG

CBC

Cannabichromene

A rare cannabinoid. Experimental studies investigate pathways related to inflammation and nociception; this is not a treatment indication.

View study · PubMed Explore further · CBC

CBN

Cannabinol

A rare cannabinoid investigated in clinical sleep studies. Findings vary with the dose and formulation studied, and cannot be generalized to every product.

View study · PubMed Explore further · CBN

CBL

Cannabicyclol

A rare cannabinoid. A 2025 experimental study investigated its interaction with the serotonin 5-HT1A receptor. This does not demonstrate clinical efficacy or establish effects of the formulation.

View study · PubMed Explore further · CBL

Δ9-THC

Delta-9-tetrahydrocannabinol

A cannabinoid with psychoactive potential and regulatory relevance. Confirm concentration in the lot COA and with the prescriber.

View study · PubMed Explore further · Δ9-THC

THCA + THCV

Acidic and varin forms

A combination shown in the Relief reference profile. Interpretation should consider the lot composition and prescriber guidance.

View study · PubMed Additional reference · PubMed Explore further · THCA Explore further · THCV

Terpenes

Not cannabinoids. They are aromatic compounds in the formulation profile; confirm their presence in the lot COA.

View study · PubMed Additional reference · PubMed Explore further · Terpenes

Educational content. Evidence may be at different stages; formulation, dosage and follow-up are defined by a qualified professional.

EXPLORE THE PRESENTATIONS

Line Precision.

PRECISION mg · mL

Harmony

PRECISION mg · mL

Relief

PRECISION mg · mL

Balance

Images are illustrative. Quantities and percentages shown are reference profiles and may vary from lot to lot. Always consult the COA for your specific lot.